SIRs for cancer in 1191 patients with SVT, stratified by type of thrombosis
| . | Overall observed cancers and SIRs (95% CI) . | |||||||
|---|---|---|---|---|---|---|---|---|
| Cancer site . | Portal vein thrombosis . | Hepatic vein thrombosis . | Mesenteric vein thrombosis . | Overall . | ||||
| Any | 161 | 4.7 (4.0-5.5) | 21 | 2.9 (1.8-4.4) | 1 | 0.5 (0.0-2.5) | 183 | 4.2 (3.6-4.9) |
| Liver | 48 | 175 (129-232) | 0 | — | 0 | — | 48 | 138 (101-182) |
| Myeloproliferative neoplasms | 15 | 111 (62-184) | 8 | 289 (125-570) | 0 | — | 23 | 133 (85-200) |
| Pancreas | 19 | 25 (15-40) | 1 | 6.3 (0.2-35) | 0 | — | 20 | 21 (13-32) |
| Hodgkin malignant lymphoma | 1 | 13 (0.3-71) | 0 | — | 0 | — | 1 | 9.7 (0.3-54) |
| Gallbladder or biliary tract | 3 | 18 (3.8-53) | 0 | — | 0 | — | 3 | 14 (2.9-41) |
| Metastases and nonspecified cancer in lymph nodes | 4 | 6.5 (1.8-17) | 1 | 7.1 (0.2-40) | 0 | — | 5 | 6.3 (2.0-15) |
| MDS | 2 | 14 (1.7-51) | 0 | — | 0 | — | 2 | 11 (1.3-38) |
| Kidney | 1 | 1.9 (0.1-10.5) | 1 | 10 (0.3-55) | 0 | — | 2 | 3.0 (0.4-11) |
| Leukemia | 3 | 5.0 (1.0-15) | 0 | — | 0 | — | 3 | 3.9 (0.8-11) |
| Non-Hodgkin malignant lymphoma | 3 | 2.8 (0.6-8.2) | 1 | 4.4 (0.1-25) | 0 | — | 4 | 3.0 (0.8-7.5) |
| Lung, bronchi, or trachea | 11 | 3.1 (1.5-5.5) | 1 | 1.5 (0.0-8.3) | 0 | — | 12 | 2.7 (1.4-4.7) |
| Colon | 5 | 2.2 (0.7-5.1) | 1 | 2.0 (0.1-11) | 0 | — | 6 | 2.0 (0.7-4.4) |
| Breast | 4 | 1.3 (0.4-3.3) | 0 | — | 1 | 3.8 (0.1-21) | 5 | 1.2 (0.4-2.8) |
| Bladder | 8 | 4.9 (2.2-9.7) | 0 | — | 0 | — | 8 | 3.9 (1.7-7.7) |
| Stomach | 3 | 6.0 (1.2-17.5) | 1 | 9.2 (0.2-52) | 0 | — | 4 | 6.3 (1.7-16) |
| Rectum | 0 | — | 2 | 7.7 (0.9-28) | 0 | — | 2 | 1.3 (0.2-4.5) |
| Uterus | 1 | 2.0 (0.1-11) | 0 | — | 0 | — | 1 | 1.5 (0.0-8.4) |
| Prostate | 6 | 1.6 (0.6-3.5) | 0 | — | 0 | — | 6 | 1.3 (0.5-2.9) |
| . | Overall observed cancers and SIRs (95% CI) . | |||||||
|---|---|---|---|---|---|---|---|---|
| Cancer site . | Portal vein thrombosis . | Hepatic vein thrombosis . | Mesenteric vein thrombosis . | Overall . | ||||
| Any | 161 | 4.7 (4.0-5.5) | 21 | 2.9 (1.8-4.4) | 1 | 0.5 (0.0-2.5) | 183 | 4.2 (3.6-4.9) |
| Liver | 48 | 175 (129-232) | 0 | — | 0 | — | 48 | 138 (101-182) |
| Myeloproliferative neoplasms | 15 | 111 (62-184) | 8 | 289 (125-570) | 0 | — | 23 | 133 (85-200) |
| Pancreas | 19 | 25 (15-40) | 1 | 6.3 (0.2-35) | 0 | — | 20 | 21 (13-32) |
| Hodgkin malignant lymphoma | 1 | 13 (0.3-71) | 0 | — | 0 | — | 1 | 9.7 (0.3-54) |
| Gallbladder or biliary tract | 3 | 18 (3.8-53) | 0 | — | 0 | — | 3 | 14 (2.9-41) |
| Metastases and nonspecified cancer in lymph nodes | 4 | 6.5 (1.8-17) | 1 | 7.1 (0.2-40) | 0 | — | 5 | 6.3 (2.0-15) |
| MDS | 2 | 14 (1.7-51) | 0 | — | 0 | — | 2 | 11 (1.3-38) |
| Kidney | 1 | 1.9 (0.1-10.5) | 1 | 10 (0.3-55) | 0 | — | 2 | 3.0 (0.4-11) |
| Leukemia | 3 | 5.0 (1.0-15) | 0 | — | 0 | — | 3 | 3.9 (0.8-11) |
| Non-Hodgkin malignant lymphoma | 3 | 2.8 (0.6-8.2) | 1 | 4.4 (0.1-25) | 0 | — | 4 | 3.0 (0.8-7.5) |
| Lung, bronchi, or trachea | 11 | 3.1 (1.5-5.5) | 1 | 1.5 (0.0-8.3) | 0 | — | 12 | 2.7 (1.4-4.7) |
| Colon | 5 | 2.2 (0.7-5.1) | 1 | 2.0 (0.1-11) | 0 | — | 6 | 2.0 (0.7-4.4) |
| Breast | 4 | 1.3 (0.4-3.3) | 0 | — | 1 | 3.8 (0.1-21) | 5 | 1.2 (0.4-2.8) |
| Bladder | 8 | 4.9 (2.2-9.7) | 0 | — | 0 | — | 8 | 3.9 (1.7-7.7) |
| Stomach | 3 | 6.0 (1.2-17.5) | 1 | 9.2 (0.2-52) | 0 | — | 4 | 6.3 (1.7-16) |
| Rectum | 0 | — | 2 | 7.7 (0.9-28) | 0 | — | 2 | 1.3 (0.2-4.5) |
| Uterus | 1 | 2.0 (0.1-11) | 0 | — | 0 | — | 1 | 1.5 (0.0-8.4) |
| Prostate | 6 | 1.6 (0.6-3.5) | 0 | — | 0 | — | 6 | 1.3 (0.5-2.9) |